✦ LIBER ✦

Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma

✍ Scribed by L Brambilla; A Miedico; S Ferrucci; A Romanelli; M Brambati; M Vinci; L Tedeschi; V Boneschi

Book ID: 111094665
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 82 KB
Volume: 20
Category: Article
ISSN: 0926-9959
DOI: 10.1111/j.1468-3083.2006.01730.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of vinblastine and bleomycin

Evaluation of vinblastine and bleomycin as second-line therapy in advanced ovarian carcinoma

✍ J. Rotmensch; N. Rosenshein; R. Donehower; D. Ettinger 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Oral etoposide as first-line therapy in

Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi’s sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

✍ F. Tas; F. Sen; S. Keskin; L. Kilic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy

Activity and Safety of Pegylated Liposom

Activity and Safety of Pegylated Liposomal Doxorubicin as First-Line Therapy in the Treatment of Non-Visceral Classic Kaposi's Sarcoma: A Multicenter Study

✍ Di Lorenzo, Giuseppe; Kreuter, Alexander; Di Trolio, Rossella; Guarini, Attilio; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Intralesional vincristine as first-line

Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients

✍ L. Brambilla; M. Bellinvia; A. Tourlaki; B. Scoppio; F. Gaiani; V. Boneschi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Hybrid chemotherapy consisting of cyclop

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease

✍ Silvia Montoto; Mireia Camós; Armando López-Guillermo; Francesc Bosch; Francisco 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## BACKGROUND. Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin disease (HD). Although a prolonged complete response (CR) is achieved in up to 70 -80% of patients, long term complications, such as secondary leukemia, are of concern. C